Univest
Univest
  • Markets

Is Jyothy Labs a Good Buy After Its Q1 FY27 Results?

  • September 4, 2026
  • Posted by: Kunal Singla
  • Category: Market
No Comments
Is Jyothy Labs a Good Buy After Its Q1 FY27 Results?

Jyothy Labs share price around Rs 202. 41.9% below 52-week high of Rs 347. Q1 FY27 revenue Rs 773 crore, up 2.9% YoY. PAT Rs 48 crore, down 50.8%. PE 26x.

Quick Answer

Jyothy Labs’ Q1 FY27 results were mixed, with revenue at Rs 773 crore but PAT falling 51% to Rs 48 crore. The Jyothy Labs share price near Rs 202 has not escaped this pressure, and the profit decline is the key data point investors should weigh before deciding whether Jyothy Labs is a good buy right now.

The Jyothy Labs share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Jyothy Labs is an FMCG company known for brands like Ujala, Exo and Margo, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.

Revenue for the quarter came in at Rs 773 crore, up 2.9% year on year, while profit after tax came in at Rs 48 crore, down 50.8% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Jyothy Labs share price from here.

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Jyothy Labs share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Jyothy Labs Q1 FY27 Financial Highlights
  • Jyothy Labs Q1 FY27 Performance Analysis
  • Key Business Factors in Q1 FY27
    • Revenue Trend
    • Margin Movement
    • Balance Sheet Position
    • Valuation Context
  • Dividend Details
  • Jyothy Labs Share Price Outlook for FY27
  • Jyothy Labs Stock Performance
  • Key Risks
    • Profitability Risk
    • Sector and Demand Risk
    • Execution Risk
  • Conclusion
  • Frequently Asked Questions on Jyothy Labs Q1 FY27 Results
    • What were Jyothy Labs’ Q1 FY27 results?
    • Is Jyothy Labs a good buy after its Q1 FY27 results?
    • What is the Jyothy Labs share price today?
    • What is Jyothy Labs’ revenue and profit for Q1 FY27?
    • Did Jyothy Labs declare a dividend with its Q1 FY27 results?
    • What is Jyothy Labs’ PE ratio and is it expensive?
    • What are the key risks for Jyothy Labs investors right now?
    • What is Jyothy Labs’ promoter shareholding?

Jyothy Labs Q1 FY27 Financial Highlights

Metric Q1 FY27 Q1 FY26 YoY Change
Revenue Rs 773 crore Rs 751 crore 2.9%
EBITDA Rs 65 crore Rs 124 crore -47.9%
Operating Margin 8.4% 16.5% NA
Profit Before Tax Rs 65 crore NA NA
Net Profit / (Loss) Rs 48 crore Rs 97 crore -50.8%

Jyothy Labs Q1 FY27 Performance Analysis

Check Jyothy Labs Fundamentals on Univest Screener

Revenue growth of 2.9% for the quarter came from steady demand across the company’s core business, keeping the topline trend intact for the home and personal care FMCG sector.

Profitability is where the quarter disappointed. PAT fell 51% year on year to Rs 48 crore even as revenue grew, which points to margin or cost pressure that management will need to address. This gap between top-line and bottom-line performance is the key thing weighing on the Jyothy Labs share price this quarter.

Sequential quarterly data was not fully available for this comparison, so investors should track the next quarter’s results to build out the trend behind the Jyothy Labs share price.

Key Business Factors in Q1 FY27

Revenue Trend

Jyothy Labs’ revenue grew 2.9% year on year this quarter, taking the quarterly base to Rs 773 crore in a home and personal care FMCG business that remains sensitive to demand and pricing cycles that ultimately feed through to the Jyothy Labs share price.

Margin Movement

EBITDA fell to Rs 65 crore from Rs 124 crore, with operating margin slipping to 8.4% from 16.5%, pointing to cost or pricing pressure that management will need to manage through the rest of FY27.

Balance Sheet Position

Jyothy Labs’ balance sheet metrics were not fully available for this quarter and should be checked against the company’s official filings before making an investment decision.

Valuation Context

Jyothy Labs does not carry a meaningful PE multiple this quarter given its current earnings, so investors should lean on revenue and book value trends instead of the price-to-earnings ratio when assessing the Jyothy Labs share price.

Dividend Details

No interim dividend was declared alongside Jyothy Labs’ Q1 FY27 results. The stock has not paid a meaningful dividend in the trailing twelve months. Investors tracking the Jyothy Labs share price for income should watch the company’s announcements around its next annual results for any dividend decision.

Jyothy Labs Share Price Outlook for FY27

The key question for the rest of FY27 is whether Jyothy Labs can arrest the margin pressure seen this quarter. Revenue growth alone will not be enough to support the Jyothy Labs share price if profitability keeps slipping, so investors should watch the next couple of quarters for signs of a turnaround in the bottom line.

A stabilising or improving margin trend in the next result would be the clearest signal that this quarter’s profit decline was a temporary setback rather than the start of a longer slide for the Jyothy Labs share price.

Jyothy Labs Stock Performance

Download the Univest iOS App or Univest Android App to track Jyothy Labs’ live share price and get daily stock updates.

The Jyothy Labs share price was trading around Rs 202 as results season played out in late August 2026, roughly 41.9% below its 52-week high of Rs 347 and well above its 52-week low of Rs 188. Promoter holding stood at 62.9% as of the June 2026 quarter.

The Jyothy Labs share price has likely already absorbed some of this quarter’s disappointment, but further downside is possible if the next results confirm the same trend rather than a one-off.

Key Risks

Profitability Risk

The quarter’s profit trend is the clearest risk here. Until Jyothy Labs shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results.

Sector and Demand Risk

As a home and personal care FMCG business, Jyothy Labs’ results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Jyothy Labs share price well before the next result.

Execution Risk

Sustaining this quarter’s trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.

Conclusion

Jyothy Labs’ Q1 FY27 results show a business still growing its top line but losing ground on profitability, with PAT down 51% to Rs 48 crore even as revenue rose. The Jyothy Labs share price reflects a stock in wait-and-watch mode, and it is not an obvious buy purely on this quarter’s numbers until the margin trend turns around.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Jyothy Labs Q1 FY27 Results

What were Jyothy Labs’ Q1 FY27 results?

Ans. Jyothy Labs reported Q1 FY27 revenue of Rs 773 crore, up 2.9% year on year, and PAT of Rs 48 crore, down 50.8% year on year.

Is Jyothy Labs a good buy after its Q1 FY27 results?

Ans. Jyothy Labs’ profitability came under pressure this quarter, which makes this a stock to watch rather than an obvious buy purely on this result. Investors should form their own view based on their own risk appetite and time horizon.

What is the Jyothy Labs share price today?

Ans. The Jyothy Labs share price was trading around Rs 202 in late August 2026, about 41.9% below its 52-week high of Rs 347 and well above its 52-week low of Rs 188.

What is Jyothy Labs’ revenue and profit for Q1 FY27?

Ans. Jyothy Labs reported revenue of Rs 773 crore and a net profit of Rs 48 crore for the quarter ended June 30, 2026.

Did Jyothy Labs declare a dividend with its Q1 FY27 results?

Ans. No interim dividend was declared alongside Jyothy Labs’ Q1 FY27 results. Investors should track the company’s next annual results for any dividend announcement.

What is Jyothy Labs’ PE ratio and is it expensive?

Ans. The Jyothy Labs share price trades at a trailing PE of 25.9x. Investors should compare this with the company’s growth rate before judging value.

What are the key risks for Jyothy Labs investors right now?

Ans. The quarter’s profit trend is the clearest risk here. Until Jyothy Labs shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results. Sustaining this quarter’s trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.

What is Jyothy Labs’ promoter shareholding?

Ans. Promoter holding in Jyothy Labs stood at 62.9% as of the June 2026 quarter.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply